Wall Street analyst estimates for Bath & Body Works, Inc. (BBWI): consensus price target, buy/hold/sell recommendations and forecasts for revenue and EPS for the upcoming fiscal years.
Bath & Body Works, Inc. operates as a specialty retailer of personal care and home fragrance products. The company offers body and home fragrances, including 3-wick candles, home fragrance diffusers, fine fragrance mists, eau de parfum, body wash, hand soaps, body lotions, and body creams, as well as sanitizer and other products.
Consensus price target
$21.17 (-7 % vs price $22.77)
between $19.00 and $24.00 · 7 targets published in the last quarter
Closing price, Oct 30
A twelve-month target is not a fair value: compare it with the range in the Valuation tab.
Revenue and EPS estimates
| Fiscal year | Revenue (average) | Revenue (low – high) | EPS (average) | Analysts |
|---|---|---|---|---|
| 2027E | $7.1B | $7.1B – $7.2B | $2.69 | 11 |
| 2028E | $7.2B | $7.1B – $7.3B | $2.76 | 12 |
Fiscal year ending in January · figures in USD · consensus as of October 29, 2026
Analyst Consensus
| Strong Buy | 0 |
| Buy | 10 |
| Hold | 11 |
| Sell | 1 |
| Strong Sell | 0 |
| Total analysts | 22 |
| Avg rating (−2 sell to +2 buy) | 0.41 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-19 | $0.11 | ||
| 2026-08-26 | $0.62 | $0.24 | +155.2% |
| 2026-05-27 | $0.32 | $0.29 | +9.8% |
| 2026-03-04 | $2.05 | $1.77 | +15.8% |
| 2025-11-20 | $0.35 | $0.38 | -8.4% |
| 2025-08-28 | $0.37 | $0.37 | +0.0% |
| 2025-05-29 | $0.49 | $0.42 | +17.3% |
| 2025-02-27 | $2.09 | $2.04 | +2.5% |
Valuation Ratios
| P/E Ratio | 6.07 |
| Price / Book | -4.36 |
| EV / EBITDA | 5.79 |
| Dividend Yield | 3.51% |
Income Statement (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.57B | $12.63B | $13.24B | $5.41B | $6.43B | $7.88B | $7.56B | $7.43B | $7.31B | $7.29B |
| Cost of Revenue | $7.45B | $7.67B | $8.34B | $3.02B | $3.34B | $4.03B | $4.30B | $4.19B | $4.07B | $4.10B |
| Gross Profit | $5.12B | $4.96B | $4.90B | $2.39B | $3.10B | $3.85B | $3.25B | $3.24B | $3.23B | $3.19B |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | $3.12B | $3.23B | $3.56B | $1.35B | $1.49B | $1.85B | $1.88B | $1.95B | $1.97B | $2.06B |
| Operating Expenses | $3.12B | $3.23B | $3.66B | $1.35B | $1.49B | $1.85B | $1.88B | $1.95B | $1.97B | $2.06B |
| Operating Income | $2.00B | $1.73B | $1.24B | $1.04B | $1.60B | $2.01B | $1.38B | $1.28B | $1.27B | $1.13B |
| EBITDA | $2.61B | $2.29B | $1.83B | $1.57B | $2.08B | $2.17B | $1.61B | $1.64B | $1.62B | $1.41B |
| Interest Expense | $394.0M | $406.0M | $385.0M | $370.0M | $432.0M | $388.0M | $348.0M | $345.0M | $312.0M | $276.0M |
| Pre-tax Income | $1.70B | $1.31B | $857.0M | $608.0M | $1.12B | $1.42B | $1.04B | $1.02B | $1.03B | $882.0M |
| Income Tax | $538.0M | $329.0M | $213.0M | $148.0M | $257.0M | $348.0M | $251.0M | $143.0M | $230.0M | $233.0M |
| Net Income | $1.16B | $983.0M | $644.0M | -$366.0M | $844.0M | $1.33B | $800.0M | $878.0M | $798.0M | $649.0M |
| EPS | $4.05 | $3.46 | $2.33 | $-1.33 | $3.04 | $4.96 | $3.45 | $3.89 | $3.62 | $3.07 |
| EPS (Diluted) | $3.98 | $3.42 | $2.31 | $-1.33 | $3.00 | $4.88 | $3.43 | $3.83 | $3.61 | $3.07 |
| Shares Outstanding (Diluted) | 291.1 M | 287.4 M | 276.2 M | 276.0 M | 281.0 M | 273.0 M | 233.0 M | 229.0 M | 221.0 M | 211.6 M |
Price
| Price | $22.77 (closing price, October 30, 2026) |
| Market Cap | $4.6B |
| Exchange | NYSE |
| Country | US |
Related companies: URBN · GNTX · REYN · ETSY · M · MTH · GPI
Explore sector: Consumer Cyclical · Specialty Retail
More sections of BBWI: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks